Inspiratory flow rates at different levels of resistance in elderly COPD patients

European Respiratory Journal

Volumn 31, Issue 1, 2008, Pages 78-83

  Janssens, W ^a,c   VandenBrande, P ^a,b   Hardeman, E ^b   De Langhe, E ^b   Philps, T ^b   Troosters, T ^a   Decramer, M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Algemeen Ziekenhuis Sint Maarten   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chronic obstructive pulmonary disease; Dry powder inhaler; Elderly; In check dial; Peak inspiratory flow

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRY POWDER; ELDERLY CARE; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; LUNG RESISTANCE; MALE; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; SPIROMETRY; AGING; CASE CONTROL STUDY; INHALATION; INHALATIONAL DRUG ADMINISTRATION; LUNG; METERED DOSE INHALER; NEBULIZER; PATHOLOGY; POWDER;

ADMINISTRATION, INHALATION; AGED; AGED, 80 AND OVER; AGING; CASE-CONTROL STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INHALATION; INSPIRATORY CAPACITY; LUNG; MALE; METERED DOSE INHALERS; NEBULIZERS AND VAPORIZERS; POWDERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 45849085803     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00024807     Document Type: Article

References (35)

1. Jones V, Fernandez C, Diggory P. A comparison of large volume spacer, breath-activated and dry powder inhalers in older people. Age Ageing 1999; 28: 481-484.
2. Roche N, Chinet T, Huchon G. Ambulatory inhalation therapy in obstructive lung diseases. Respiration 1997; 64: 121-130.
3. Sumby B, Slater A, Atkins PJ, Prime D. Review of dry powder inhalers. Adv Drug Deliv Rev 1997; 26: 51-58.
4. Broeders ME, Molema J, Vermue NA, Folgering HT. Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers. Eur Respir J 2001; 18: 780-783.
5. Broeders ME, Molema J, Hop WC, Folgering HT. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction. J Aerosol Med 2003; 16: 131-141.
6. Broeders ME, Molema J, Vermue NA, Folgering HT. In Check Dial: accuracy for Diskus and Turbuhaler. Int J Pharm 2003; 252: 275-280.
7. Bronsky EA, Grossman J, Henis MJ, et al. Inspiratory flow rates and volumes with the Aerolizer dry powder inhaler in asthmatic children and adults. Curr Med Res Opin 2004; 20: 131-137.
8. Clark AR, Hollingworth AM. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers-implications for in vitro testing. J Aerosol Med 1993; 6: 99-110.
9. Amirav I, Newhouse MT, Mansour Y. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma. Pediatr Pulmonol 2005; 39: 447-451.
10. Adachi YS, Adachi Y, Itazawa T, Yamamoto J, Murakami G, Miyawaki T. Ability of preschool children to use dry powder inhalers as evaluated by In-Check Meter. Pediatr Int 2006; 48: 62-65.
11. Broeders ME, Molema J, Hop WC, Vermue NA, Folgering HT. The course of inhalation profiles during an exacerbation of obstructive lung disease. Respir Med 2004; 98: 1173-1179.
12. Richter K. Successful use of DPI systems in asthmatic patients-key parameters. Respir Med 2004; 98: Suppl. B, S22-S27.
13. Engel T, Heinig JH, Madsen F, Nikander K. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler). Eur Respir J 1990; 3: 1037-1041.
14. Chrystyn H. Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates. Respir Med 2003; 97: 181-187.
15. Diggory P, Fernandez C, Humphrey A, Jones V, Murphy M. Comparison of elderly people's technique in using two dry powder inhalers to deliver zanamivir: randomised controlled trial. BMJ 2001; 322: 577-579.
16. Nsour WM, Alldred A, Corrado J, Chrystyn H. Measurement of peak inhalation rates with an in-check meter to identify an elderly patient's ability to use a turbuhaler. Respir Med 2001; 95: 965-968.
17. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999; 13: 197-205.
18. Jarvis S, Ind PW, Shiner RJ. Inhaled therapy in elderly COPD patients; time for re-evaluation? Age Ageing 2007; 36: 213-218.
19. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40.
20. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969; 99: 696-702.
21. van der Palen J. Peak inspiratory flow through diskus and turbuhaler, measured by means of a peak inspiratory flow meter (In-Check DIAL). Respir Med 2003; 97: 285-289.
22. Meakin BJ, Ganderton D, Panza I, Ventura P. The effect of flow rate on drug delivery from the Pulvinal, a high-resistance dry powder inhaler. J Aerosol Med 1998; 11: 143-152.
23. Prime D, Grant AC, Slater AL, Woodhouse RN. A critical comparison of the dose delivery characteristics of four alternative inhalation devices delivering salbutamol: pressurized metered dose inhaler, Diskus inhaler, Diskhaler inhaler, and Turbuhaler inhaler. J Aerosol Med 1999; 12: 75-84.
24. Bisgaard H, Klug B, Sumby BS, Burnell PK. Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma. Eur Respir J 1998; 11: 1111-1115.
25. Chew NY, Chan HK. In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler. J Aerosol Med 2001; 14: 495-501.
26. Borgström L. Deposition patterns with Turbuhaler. J Aerosol Med 1994; 7: Suppl. 1, S49-S53.
27. Borgstrom L, Bondesson E, Moren F, Trofast E, Newman SP. Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects. Eur Respir J 1994; 7: 69-73.
28. Nielsen KG, Auk IL, Bojsen K, Ifversen M, Klug B, Bisgaard H. Clinical effect of Diskus dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children. Eur Respir J 1998; 11: 350-354.
29. Tarsin WY, Pearson SB, Assi KH, Chrystyn H. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics. Int J Pharm 2006; 316: 131-137.
30. Nielsen KG, Skov M, Klug B, Ifversen M, Bisgaard H. Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizer. Eur Respir J 1997; 10: 2105-2109.
31. Derom E, Borgstrom L, Van Schoor J, Lofroos AB, Pauwels R. Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals. Am J Respir Crit Care Med 2001; 164: 1398-1402.
32. Dewar MH, Jamieson A, McLean A, Crompton GK. Peak inspiratory flow through Turbuhaler in chronic obstructive airways disease. Respir Med 1999; 93: 342-344.
33. Parry-Billings M, Birrell C, Oldham L, O'Callaghan C. Inspiratory flow rate through a dry powder inhaler (Clickhaler) in children with asthma. Pediatr Pulmonol 2003; 35: 220-226.
34. Sarinas PS, Robinson TE, Clark AR, Canfield J Jr, Chitkara RK, Fick RB Jr. Inspiratory flow rate and dynamic lung function in cystic fibrosis and chronic obstructive lung diseases. Chest 1998; 114: 988-992.
35. Cegla UH. Pressure and inspiratory flow characteristics of dry powder inhalers. Respir Med 2004; 98: Suppl. A, S22-S28.